CN118384114B — 一种氯化钾颗粒及其制备工艺
Assigned to Zhejiang Tongwu Biopharmaceutical Co ltd · Expires 2024-11-22 · 1y expired
What this patent protects
本发明属于医药技术领域，具体涉及一种氯化钾颗粒及其制备工艺。按重量分数计，所述氯化钾颗粒的原料包括：氯化钾14‑16份、调节剂0.1‑0.2份、助流剂0.1‑0.2份、矫味剂0.05‑0.2份、甜味剂0.3‑0.4份、着色剂0.02‑0.1份和芳香剂0.15‑0.25份；所述调节剂为甘露醇、羟丙基β‑环糊精和精氨酸的混合物。本发明的氯化钾颗粒外观均匀，含量均匀度好、流动性佳，增加了病人的顺应性。
USPTO Abstract
本发明属于医药技术领域，具体涉及一种氯化钾颗粒及其制备工艺。按重量分数计，所述氯化钾颗粒的原料包括：氯化钾14‑16份、调节剂0.1‑0.2份、助流剂0.1‑0.2份、矫味剂0.05‑0.2份、甜味剂0.3‑0.4份、着色剂0.02‑0.1份和芳香剂0.15‑0.25份；所述调节剂为甘露醇、羟丙基β‑环糊精和精氨酸的混合物。本发明的氯化钾颗粒外观均匀，含量均匀度好、流动性佳，增加了病人的顺应性。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.